Are you Dr. Spitler?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 33 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
450 Stanyan St
Norther California Melanoma Center St. Mary's Med Cente
San Francisco, CA 94117Phone+1 415-750-5660Fax+1 415-750-4860
Summary
- Dr. Lynn Spitler, MD is an allergist/immunologist in San Francisco, California. She is currently licensed to practice medicine in California. She is affiliated with St. Mary's Medical Center.
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 1967 - 1969- University of California (San Francisco)Residency, Internal Medicine, 1964 - 1966
Alameda Health System-Highland HospitalInternship, Transitional Year, 1963 - 1964
University of Michigan Medical SchoolClass of 1963- University of California (San Francisco)Fellowship, Ocular Immunology/Uveitis
Certifications & Licensure
CA State Medical License 1964 - 2018- American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery Start of enrollment: 1999 Dec 01
- Temodar and Sutent as Therapy for Melanoma Start of enrollment: 2006 Mar 01
- GM-CSF as Adjuvant Therapy of Melanoma Start of enrollment: 2004 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 37 citationsClinical Responses of Oncolytic Coxsackievirus A21 (V937) in Patients With Unresectable Melanoma.Robert H.I. Andtbacka, Brendan D. Curti, Gregory A. Daniels, Sigrun Hallmeyer, Eric D. Whitman
Journal of Clinical Oncology. 2021-08-31 - 43 citationsA phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.Patrick A. Ott, Anna C. Pavlick, Douglas B. Johnson, Lowell L. Hart, Jeffrey R. Infante
Cancer. 2019-04-01 - 7 citationsBiological Effects of Anti-Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Antibody Formation in Patients Treated With GM-CSF (Sargramostim) as Adjuvant Ther...Lynn E Spitler, Huynh Cao, Timo Piironen, Theresa L Whiteside, Robert W. Weber
American Journal of Clinical Oncology. 2017-04-01
Press Mentions
Edmond ‘Ted’ Eger, Pioneering Anesthesiologist, DiesOctober 6th, 2017
Professional Memberships
- Member
